The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all ...

Many believe the federal program limits healthcare organizations and hospitals from providing discounted medications.

The 340B Program has continued to undergo significant upheaval in 2024 that has the potential to bring about impactful changes to how the 340B Program operates moving forward. These developments have ...

Data sovereignty key navigating 340B's future helps healthcare leaders build integrated data systems for compliance and ...

The 340B Drug Pricing Program (340B Program) is no stranger to controversy. We have previously covered the ongoing contract pharmacy legal battles and the new alternative dispute resolution process.

What does it mean to be a patient? For some, it means access to the best doctors and hospitals. For others, it means a courageous battle against a chronic, and perhaps incurable disease. And for many, ...

Your recent opinion piece on the 340B drug discount program (December 18, “Drug discount program remains vital to support healthcare services”) provides a somewhat deceptive picture of the 340B ...

The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992, ...

Rescription, Inc., a leading innovator in pharmacy benefit management, is proud to announce it has been awarded a U.S.

Medicare’s Maximum Fair Price (MFP) officially went live on January 1st. Select Medicare Part D drugs are now subject to negotiated pricing under the Inflation Reduction Act, with 15 additional Part D ...

Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues. If your health system ...